In this article we are going to address the topic of AP5 from a multidisciplinary perspective, with the aim of providing the reader with a comprehensive and analytical vision of this topic. To do this, we will take a tour of different aspects related to AP5, such as its origin, evolution, impact on current society, and possible future scenarios. In addition, we will focus on the importance of AP5 in various fields of knowledge, as well as its relevance in people's daily lives. Through this article, we aim to generate a deep and enriching reflection on AP5, thus promoting greater understanding and appreciation for this topic that is so relevant today.
| Names | |
|---|---|
| Preferred IUPAC name
(2R)-2-Amino-5-phosphonopentanoic acid | |
| Identifiers | |
3D model (JSmol)
|
|
| ChemSpider | |
| ECHA InfoCard | 100.150.904 |
PubChem CID
|
|
| UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C5H12NO5P | |
| Molar mass | 197.13 g/mol |
| Appearance | white solid |
| Density | 1.529 g/mL |
| Boiling point | 482.1 °C (899.8 °F; 755.2 K) |
| Ammonium hydroxide, 50 mg/mL | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa).
| |
AP5 (also known as APV, (2R)-amino-5-phosphonovaleric acid, or (2R)-amino-5-phosphonopentanoate) is a chemical compound used as a biochemical tool to study various cellular processes. It is a selective NMDA receptor antagonist that competitively inhibits the ligand (glutamate) binding site of NMDA receptors.[1] AP5 blocks NMDA receptors in micromolar concentrations (~50 μM).
AP5 blocks the cellular analog of classical conditioning in the sea slug Aplysia californica, and has similar effects on Aplysia long-term potentiation (LTP), since NMDA receptors are required for both.[2] It is sometimes used in conjunction with the calcium chelator BAPTA to determine whether NMDARs are required for a particular cellular process. AP5/APV has also been used to study NMDAR-dependent LTP in the mammalian hippocampus.[3]
In general, AP5 is very fast-acting within in vitro preparations, and can block NMDA receptor action at a reasonably small concentration. The active isomer of AP5 is considered to be the D configuration, although many preparations are available as a racemic mixture of D- and L-isomers. It is useful to isolate the action of other glutamate receptors in the brain, i.e., AMPA and kainate receptors.
AP5 can block the conversion of a silent synapse to an active one, since this conversion is NMDA receptor-dependent.